Valuation GSK plc

Equities

Market Closed - London S.E. Other stock markets 16:35:05 13/03/2026 GMT			5-day change	1st Jan Change
2,031.00 ^GBX	0.00%		-0.34%	+11.32%

03-13	GSK and Amgen to add medicines to TrumpRx, Fox Business reports	RE
03-13	GSK plc Announces Expansion of AREXVY Approval to Adults Aged 18 to 49 Years for RSV Prevention	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Capitalization ¹	80,458	58,381	59,112	54,944	73,201	81,320	-	-
Change	-	-27.44%	1.25%	-7.05%	33.23%	11.09%	-	-
Enterprise Value (EV) ¹	100,296	75,578	74,152	68,039	87,654	93,302	90,573	88,591
Change	-	-24.65%	-1.89%	-8.24%	28.83%	6.44%	-2.92%	-2.19%
P/E ratio	18.6x	3.93x	11.9x	21.3x	12.9x	12.7x	11.8x	11.3x
PBR	5.34x	5.47x	4.4x	4.02x	-	4.33x	3.61x	3.2x
PEG	-	0x	-0.2x	-0.4x	0x	1x	1.52x	2.67x
Capitalization / Revenue	2.36x	1.99x	1.95x	1.75x	2.24x	2.41x	2.3x	2.23x
EV / Revenue	2.94x	2.58x	2.45x	2.17x	2.68x	2.76x	2.56x	2.43x
EV / EBITDA	8.85x	7.23x	6.37x	6.36x	7.77x	7.99x	7.3x	7x
EV / EBIT	11.4x	9.27x	8.44x	7.44x	8.96x	9.17x	8.22x	7.62x
EV / FCF	22.6x	12.1x	13.6x	13x	13.7x	14.6x	14.1x	12.4x
FCF Yield	4.42%	8.28%	7.36%	7.67%	7.32%	6.84%	7.09%	8.09%
Dividend per Share ²	1	0.6125	0.58	0.61	0.66	0.693	0.761	0.7633
Rate of return	4.98%	4.26%	4%	4.53%	3.62%	3.41%	3.75%	3.76%
EPS ²	1.082	3.662	1.216	0.632	1.411	1.594	1.717	1.79
Distribution rate	92.4%	16.7%	47.7%	96.5%	46.8%	43.5%	44.3%	42.6%
Net sales ¹	34,114	29,324	30,328	31,376	32,667	33,804	35,419	36,517
EBITDA ¹	11,330	10,449	11,635	10,693	11,278	11,681	12,415	12,648
EBIT ¹	8,806	8,151	8,786	9,148	9,783	10,174	11,021	11,627
Net income ¹	4,385	14,956	4,928	2,575	5,716	6,311	6,796	7,183
Net Debt ¹	19,838	17,197	15,040	13,095	14,453	11,982	9,253	7,272
Reference price ²	20.08	14.38	14.50	13.46	18.24	20.31	20.31	20.31
Nbr of stocks (in thousands)	4,006,383	4,060,999	4,076,145	4,080,519	4,012,126	4,003,922	-	-
Announcement Date	09/02/22	01/02/23	31/01/24	05/02/25	04/02/26	-	-	-

¹GBP in Million²GBP

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
GSK PLC	12.75x	2.76x	7.99x	3.41%	108B
ELI LILLY AND COMPANY	28.95x	10.91x	21.91x	0.67%	880B
JOHNSON & JOHNSON	25.63x	5.96x	16.23x	2.19%	582B
ABBVIE INC.	24x	6.55x	13.15x	3.16%	388B
ROCHE HOLDING AG	17.32x	4.22x	10.43x	3.13%	324B
ASTRAZENECA PLC	23.94x	4.99x	13.83x	1.75%	295B
NOVARTIS AG	20.93x	5.64x	13.96x	2.87%	293B
MERCK & CO., INC.	27.02x	4.74x	14.82x	2.92%	286B
AMGEN INC.	24.64x	6.26x	11.14x	2.74%	197B
GILEAD SCIENCES, INC.	20.1x	6.12x	11.06x	2.25%	180B
Average	22.53x	5.82x	13.45x	2.51%	353.38B
Weighted average by Cap.	24.37x	6.82x	15.47x	2.15%